Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatments using transgenic goat produced antithrombin III

Treatments using transgenic goat produced antithrombin III

US Patent 7019193 · Granted Mar 28, 2006

Estimated economic value: $1,576,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Highly galactosylated anti-TNF-α antibodies and uses thereof2019
Proteins with modified glycosylation and methods of production thereof2018
Non-human transgenic mammal expressing a human FcRn on its mammary gland cells a2012
Transgenically produced antithrombin III2011
Transgenically produced antithrombin III2011
Transgenically produced antithrombin III2011
Modified nucleic acid sequences and methods for increasing mRNA levels and prote2009
Method for the production of fusion proteins in transgenic mammal milk2009
Non-human transgenic mammal comprising a modified MSP-1 nucleic acid2009
Merozoite surface protein 1 lacking glycosylation sites2008
Anticancer peptide compositions2008
Erythropoietin analog-human serum albumin fusion2006